HYPERPROLACTINEMIA DURING FAMOTIDINE THERAPY

被引：5
作者：
DELPRE, G
LAPIDOT, M
LIPCHITZ, A
LIVNI, E
KADISH, U
机构：
[1] BEILINSON MED CTR,INST ADULT ENDOCRINOL,IL-49100 PETAH TIQWA,ISRAEL
[2] TEL AVIV UNIV,SACKLER FAC MED,IL-69978 TEL AVIV,ISRAEL
来源：
LANCET | 1993年 / 342卷 / 8875期
关键词：
D O I：
10.1016/0140-6736(93)92729-D
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：868 / 868
页数：1
相关论文
共 6 条
[1]   IMMUNOLOGICAL STUDIES IN A CASE OF HEPATITIS FOLLOWING METHYLDOPA ADMINISTRATION [J].
DELPRE, G ;
GRINBLAT, J ;
KADISH, U ;
LIVNI, E ;
SHOHAT, B ;
LEWITUS, Z ;
JOSHUA, H .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1979, 277 (02) :207-213
[2]  
GIUSTI M, 1986, CLIN PHARMACOL THER, V14, P3
[3]  
HAYAKAWA A, 1984, ITAL J GASTROENTEROL, V16, P174
[4]  
LANGMAN MJ, 1988, SAFE EFFECTIVE CONTR, P135
[5]   FAMOTIDINE - AN UPDATED REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC USE IN PEPTIC-ULCER DISEASE AND OTHER ALLIED DISEASES [J].
LANGTRY, HD ;
GRANT, SM ;
GOA, KL .
DRUGS, 1989, 38 (04) :551-590
[6]  
SANTUCCI L, 1991, NEW ENGL J MED, V324, P635
1